secwatch / observer

Executive movement radar

Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.

Launch 76387 grounded facts newest September 3, 2026, 5:10 PM ET RSS · JSON

Showing 8001–8050 of 76387

Appointed

Bant Breen

Class I member of the Board of Directors
SLE · Super League Enterprise, Inc.
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
Effective April 1, 2025, the Company appointed Bant Breen as a Class I member of the Board of Directors of the Company
Departed

Clark Callandar

Class I member of the Board of Directors
SLE · Super League Enterprise, Inc.
Effective
2025-03-31
Successor
Bant Breen
Filed
April 3, 2025, 7:59 PM ET
Effective March 31, 2025, Clark Callandar resigned as a Class I member of the Board of Directors of the Company.
Role change

Ann Hand

Executive Chair
SLE · Super League Enterprise, Inc.
Effective
2025-04-01
Successor
Matthew Edelman
Filed
April 3, 2025, 7:59 PM ET
Ann Hand, who was appointed Executive Chair effective April 1, 2025
Departed

Karen Sims

Chief Medical Officer
ABUS · Arbutus Biopharma Corp
Effective
2025-03-25
Filed
April 3, 2025, 7:59 PM ET
the Company terminated, without cause, Karen Sims, M.D., Ph.D. as Chief Medical Officer of the Company, effective March 25, 2025.
Departed

David Hastings

Chief Financial Officer
ABUS · Arbutus Biopharma Corp
Effective
2025-03-27
Filed
April 3, 2025, 7:59 PM ET
the Company terminated, without cause, David Hastings as Chief Financial Officer of the Company, effective as of the end of the day on March 27, 2025.
Departed

Robert Synowicki, Jr.

Director
KNX · Knight-Swift Transportation Holdings Inc.
Filed
April 3, 2025, 7:59 PM ET
On April 1, 2025, Robert Synowicki, Jr. confirmed to Knight-Swift Transportation Holdings Inc. (the "Company") that he will not be standing for reelection at the Company’s 2025 Annual Meeting of Stockholders.
Departed

Mark Mason

Chairman, Chief Executive Officer and President
MCHB · Mechanics Bancorp
Filed
April 3, 2025, 7:59 PM ET
HomeStreet and Mechanics Bank entered into a consulting agreement (the “ Consulting Agreement ”) with Mark Mason, the Chairman, Chief Executive Officer and President of HomeStreet, pursuant to which Mr. Mason’s employment with HomeStreet and HomeStreet Bank will terminate on the first day following the closing of the Merger
Departed

Thomas J. DeRosa

Director
ESRT · Empire State Realty Trust, Inc.
Effective
2025-05-15
Filed
April 3, 2025, 7:59 PM ET
Thomas J. DeRosa, a member of the board of directors (the “Board”), Chair of the Compensation Committee and a member of the Audit Committee of Empire State Realty Trust, Inc. (the “Company”), notified the Company of his intention to retire and not stand for re-election to the Board at the Company’s 2025 Annual Meeting of Shareholders, currently expected to be held on May 15, 2025 (the “Annual Meeting”).
Appointed

Ron Philip

Class III director
HRMY · Harmony Biosciences Holdings, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
Effective April 2, 2025, the Board of Directors (the “Board”) of Harmony Biosciences Holdings, Inc. (the “Company”) appointed Ron Philip, age 51, as a Class III director, filling the previously announced vacancy in the Board created by the resignation of Jack Bech Nielsen effective June 27, 2024.
Departed

C. Robert Kehler

Director
ASLE · AerSale Corp
Filed
April 3, 2025, 7:59 PM ET
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
Departed

Peter Nolan

Director
ASLE · AerSale Corp
Filed
April 3, 2025, 7:59 PM ET
each of Peter Nolan and General C. Robert Kehler notified the Company of their intent not to stand for re-election as a member of the Board at the 2025 Annual Meeting
Appointed

Carol DiBattiste

Director
ASLE · AerSale Corp
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
Appointed

Thomas D. Mitchell

Director
ASLE · AerSale Corp
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
appointed Carol DiBattiste, and Thomas D. Mitchell, to serve as independent members of the Board to fill the Board’s current vacancies, effective April 1, 2025
Appointed

Jerry Jao

Member of the Board, Chairperson of the Audit Committee, Member of the Compensation Committee
FIGS · FIGS, Inc.
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
On March 31, 2025, the board of directors (the “ Board ”) of FIGS, Inc. (the “ Company ”) appointed Jerry Jao to serve as a member of the Board, effective April 1, 2025 (the “ Effective Date ”).
Departed

Alexander Baum

Director
NSIT · INSIGHT ENTERPRISES INC
Filed
April 3, 2025, 7:59 PM ET
On March 28, 2025, Alexander Baum notified the Board of Directors (the “Board”) of Insight Enterprises, Inc. (the “Company”) that he intends to retire from the Board and will not stand for election at the Company’s next annual meeting of stockholders (the “2025 Annual Meeting”).
Appointed

Forrest Robinson

Chief Accounting Officer
PTEN · PATTERSON UTI ENERGY INC
Effective
2025-04-03
Filed
April 3, 2025, 7:59 PM ET
On April 3, 2025, the Board of Directors of Patterson-UTI Energy, Inc. (the “Company”) approved the appointment of Forrest Robinson, 41, to the position of Chief Accounting Officer, effective immediately.
Appointed

Harsh Rungta

Senior Vice President, Finance and Chief Accounting Officer
ACHR · Archer Aviation Inc.
Effective
2025-03-31
Filed
April 3, 2025, 7:59 PM ET
On March 31, 2025, Archer Aviation Inc. (the “Company”) announced the appointment of Harsh Rungta as its Senior Vice President, Finance and Chief Accounting Officer, effective immediately.
Appointed

Robert A. DeMichiei

director
ARDT · Ardent Health, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
it has increased the size of the Company’s Board of Directors (the "Board") to 11 members and has appointed Robert A. DeMichiei to fill the newly created seat on the Board, effective April 2, 2025.
Departed

Anthony Kerrigone

officer and director
BLNH · Blue Line Holdings, Inc.
Effective
2025-03-31
Successor
Joseph C. Henn
Filed
April 3, 2025, 7:59 PM ET
Following the appointment of Mr. Henn as an officer and director, Anthony Kerrigone resigned as an officer and director of the Company.
Appointed

Joseph C. Henn

Chief Executive, Financial and Accounting Officer and Secretary
BLNH · Blue Line Holdings, Inc.
Effective
2025-03-31
Filed
April 3, 2025, 7:59 PM ET
On March 31, 2025 Joseph C. Henn was appointed as a director, the Company’s Chief Executive, Financial and Accounting Officer and the Company’s Secretary.
Departed

William Myrick

Partner
Shepherd's Finance, LLC
Effective
2025-03-31
Filed
April 3, 2025, 7:59 PM ET
On March 31, 2025, William Myrick was terminated from his position as the Partner of Shepherd’s Finance, LLC (the “Company”) without cause.
Departed

Aurora Cassirer

Director
FEED · ENvue Medical, Inc.
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
On April 1, 2025, Aurora Cassirer submitted her resignation as a member of the board of directors of NanoVibronix, Inc. (the “Company”), which resignation became effective immediately.
Departed

Darren W. Spriggs

Chief Financial Officer, Treasurer, and Corporate Secretary
ENGLOBAL CORP
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
On April 1, 2025, Darren W. Spriggs resigned as Chief Financial Officer, Treasurer, and Corporate Secretary of ENGlobal Corporation (the “Company”).
Departed

Khachactur Mkrtchyan

Chairman, President, Chief Executive Officer
LEGEND SPICES, INC.
Effective
2025-03-29
Successor
Qihui Wang
Filed
April 3, 2025, 7:59 PM ET
As of March 29, 2025, Khachactur Mkrtchyan, the Chairman, President, Chief Executive Officer, (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer) of Legend Spices, Inc. (the “Company”), is no longer holding the positions.
Appointed

Qihui Wang

Chairman, President, Chief Executive Officer
LEGEND SPICES, INC.
Effective
2025-03-29
Filed
April 3, 2025, 7:59 PM ET
The Board of the Company appointed Qihui Wang as the Chairman, President, Chief Executive Officer, (Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer), effective March 29, 2025.
Role change

Kurt Hoff

Chief Revenue Officer
LTRX · LANTRONIX INC
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
Effective April 1, 2025, Mr. Hoff was promoted to the position of Chief Revenue Officer.
Role change

Mathi Gurusamy

Chief Product and Strategy Officer
LTRX · LANTRONIX INC
Effective
2025-04-01
Filed
April 3, 2025, 7:59 PM ET
Effective April 1, 2025, Mr. Gurusamy was promoted to the position of Chief Product and Strategy Officer.
Appointed

William Devereux

Chief Financial Officer
SBEV · SPLASH BEVERAGE GROUP, INC.
Effective
2025-03-20
Filed
April 3, 2025, 7:59 PM ET
On March 20, 2025, the Board of Directors of Splash Beverage Group, Inc. (the “Company”) appointed Mr. William “Bill” Devereux to serve as Chief Financial Officer of the Company, effective as of the same date.
Appointed

Thomas Fore

Director
SBEV · SPLASH BEVERAGE GROUP, INC.
Effective
2025-03-20
Filed
April 3, 2025, 7:59 PM ET
Simultaneously, the Board of Directors of the Company appointed Mr. Thomas Fore to serve as a Director of the Company, effective March 20, 2025.
Departed

Judy Su

member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed

Charn Deol

member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed

Usama Chaudhry

Chief Financial Officer
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On the same date, Usama Chaudhry resigned from his position as Chief Financial Officer of the Company, effective immediately.
Departed

Esha Randhawa

member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, and Judy Su each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed

Esha Randhawa

Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed

Usama Chaudhry

Chief Financial Officer
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On the same date, Ms. Field also resigned from her position as Vice President, and Usama Chaudhry resigned from his position as Chief Financial Officer of the Company, each effective immediately.
Departed

Judy Su

Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed

Charn Deol

Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Departed

Katharyn Field

Vice President
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On the same date, Ms. Field also resigned from her position as Vice President, and Usama Chaudhry resigned from his position as Chief Financial Officer of the Company, each effective immediately.
Departed

Katharyn Field

Member of the Board of Directors
Virpax Pharmaceuticals, Inc.
Effective
2025-04-02
Filed
April 3, 2025, 7:59 PM ET
On April 2, 2025, Esha Randhawa, Charn Deol, Judy Su, and Katharyn Field each resigned from their positions as members of the Board of Directors of the Company, effective immediately.
Appointed

Genismarlon Da Silva Nunes

Independent Director
GSMT · Global-Smart.Tech
Effective
2025-03-31
Filed
April 3, 2025, 7:59 PM ET
On March 31, 2025, the Board of Directors Global-Smart.Tech Inc. (“the Board”), appointed Genismarlon Da Silva Nunes to serve as an Independent Director of the Global-Smart.Tech Inc. (“the Company”), effective immediately.
Appointed (interim)

Martin Egan

Interim Chief Financial Officer
TBBK · Bancorp, Inc.
Effective
2025-03-28
Filed
April 3, 2025, 7:59 PM ET
On March 28, 2025, the Board of Directors (the “Board”) of the Company appointed Martin Egan, 57, the Company’s current Chief Accounting Officer, as the Company’s Interim Chief Financial Officer.
Departed

Paul Frenkiel

Executive Vice President, Chief Financial Officer and Secretary
TBBK · Bancorp, Inc.
Effective
2025-03-28
Successor
Martin Egan
Filed
April 3, 2025, 7:59 PM ET
On March 28, 2025, Paul Frenkiel, 72, announced his retirement from his position as the Executive Vice President, Chief Financial Officer and Secretary of The Bancorp, Inc.
Appointed

Matthew Runkle

Board of Directors
LNG · Cheniere Energy, Inc.
Effective
2025-04-01
Filed
April 2, 2025, 7:59 PM ET
On April 1, 2025, Matthew Runkle was appointed to the Board of Directors (the “Board”) of Cheniere Energy, Inc. (the “Company”) pursuant to a right granted to CQP Holdco LP (f/k/a Blackstone CQP Holdco LP), a Delaware limited partnership, in an Investors’ and Registration Rights Agreement (the “Agreement”) dated as of July 31, 2012, among Cheniere Energy Partners, L.P., Cheniere Energy Partners GP, LLC, the Company, CQP Holdco LP and the other investor party thereto.
Departed

Scott Peak

Board of Directors
LNG · Cheniere Energy, Inc.
Effective
2025-04-01
Successor
Matthew Runkle
Filed
April 2, 2025, 7:59 PM ET
In connection with the appointment of Mr. Runkle and pursuant to the terms of the Agreement, Scott Peak resigned from the Board on April 1, 2025.
Role change

Lei Schiltz

Vice President and President, Global Products & Solutions
JCI · Johnson Controls International plc
Effective
2025-04-01
Filed
April 2, 2025, 7:59 PM ET
Lei Schiltz, the Company’s Vice President and President, Global Products, has assumed the new role of Vice President and President, Global Products & Solutions
Departed

Cort O'Haver

Executive Chair
COLB · COLUMBIA BANKING SYSTEM, INC.
Effective
2025-03-31
Successor
Maria Pope
Filed
April 2, 2025, 7:59 PM ET
On March 30, 2025, the board of directors of Columbia Banking System, Inc. (the "Company") determined that Mr. Cort O’Haver, the Executive Chair of the Company’s board of directors, would no longer serve as Executive Chair, effective as of March 31, 2025.
Appointed

Maria Pope

independent, non-executive chair
COLB · COLUMBIA BANKING SYSTEM, INC.
Effective
2025-04-01
Filed
April 2, 2025, 7:59 PM ET
the board elected director Maria Pope to serve as the independent, non-executive chair of the Company’s board of directors, effective April 1, 2025.
Appointed

Teresa Marie Bitetti

Class II Director
AURA · Aura Biosciences, Inc.
Effective
2025-03-31
Filed
April 2, 2025, 7:59 PM ET
unanimously appointed Teresa Marie Bitetti, MBA, as a Class II director, effective March 31, 2025
Appointed

Jonathan Pollack

member of the Board
SWDR · Starwood Real Estate Income Trust, Inc.
Effective
2025-04-01
Filed
April 2, 2025, 7:59 PM ET
On March 31, 2025, the board of directors (the “Board”) of Starwood Real Estate Income Trust, Inc. (the “Company”) appointed Jonathan Pollack to serve as a member of the Board, effective April 1, 2025.
Appointed (interim)

Daniel Hoehn

Interim Chief Financial Officer
MYE · MYERS INDUSTRIES INC
Effective
2025-05-02
Filed
April 2, 2025, 7:59 PM ET
Daniel Hoehn, the Company’s Vice President and Corporate Controller, will be named Interim Chief Financial Officer effective upon Mr. Fitz’s departure.

Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.